Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
February 12 2025 - 4:02PM
Edgar (US Regulatory)
EXHIBIT 1
EVIDENCE OF SIGNATORY AUTHORITY
Excerpt from Commercial Register of Novartis Pharma
AG
Identification number |
Legal status |
Entry |
Cancelled |
|
|
|
|
|
|
|
1 |
CHE-106.052.527 |
Limited or Corporation |
25.10.1989 |
|
|
|
All data
In |
Ca |
Business name |
Ref |
Legal seat |
1 |
|
Novartis Pharma AG |
1 |
Basel |
1 |
|
(Novartis Pharma SA) (Novartis Pharma Inc.) |
|
|
CHE-106.052.527 |
|
|
Novartis Pharma AG |
|
Basel |
3 |
All data |
|
|
|
|
|
|
In |
Mo |
Ca |
Personal Data |
Function |
Signature |
|
78 |
|
Rehm, Christian Jakob, von Illanz/Glion, in Zug |
secretary (out of the board) |
joint signature at two |
CHE-106.052.527 |
|
|
Novartis
Pharma AG |
|
Basel |
3 |
All data |
|
|
|
|
|
|
In |
Mo |
Ca |
Personal Data |
Function |
Signature |
|
55 |
|
Foertsch, Lukas, von Zürich, in Sissach |
|
joint signature at two |
Excerpt from Commercial Register of Novartis AG
Identification number |
Legal status |
Entry |
Cancelled |
|
|
|
|
|
|
|
1 |
CHE-103.867.266 |
Limited or Corporation |
01.03.1996 |
|
|
|
All data
In |
Ca |
Business name |
Ref |
Legal seat |
1 |
|
Novartis AG |
1 |
Basel |
1 |
|
(Novartis SA) (Novartis Inc.) |
|
|
CHE-103.867.266 |
|
|
Novartis AG |
|
Basel |
3 |
All data |
|
|
|
|
|
|
In |
Mo |
Ca |
Personal Data |
Function |
Signature |
|
28 |
|
Rehm, Christian Jakob, von Illanz/Glion, in Zug |
|
joint signature at two |
CHE-103.867.266 |
|
|
Novartis AG |
|
Basel |
3 |
All data |
|
|
|
|
|
|
In |
Mo |
Ca |
Personal Data |
Function |
Signature |
|
14 |
|
Foertsch, Lukas, von Zürich, in Sissach |
|
joint signature at two |
Erasca (NASDAQ:ERAS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Erasca (NASDAQ:ERAS)
Historical Stock Chart
From Feb 2024 to Feb 2025